INTRODUCTION
============

The kinetochore is the chromosomal attachment site of spindle microtubules and is required for faithful chromosome segregation. Point centromeres in budding yeasts are small (∼125 base pairs), whereas regional centromeres of fission yeast and other multicellular eukaryotes are large (4--10,000 kb) and contain repetitive DNA ([@B7]). The kinetochore is a large macromolecular structure of \>100 proteins categorized as inner, middle, or outer kinetochore proteins, depending on their proximity to centromeric DNA or the microtubules. The middle kinetochore, containing the COMA complex (Ctf19, Okp1, Mcm21, and Ame1), serves as a linker between the inner and outer kinetochore. The outer kinetochore, containing the Ndc80 and Dam1 complexes, mediates the attachment of the kinetochores to microtubules ([@B17]; [@B27]). Defects in spindle--kinetochore interactions lead to cell cycle delay dependent on the spindle assembly checkpoint (SAC), which inhibits activation of the anaphase-promoting complex (APC). The APC is inactive until all chromosomes are correctly aligned at the metaphase plate, thereby preventing premature entry into anaphase and minimizing chromosome missegregation ([@B15]).

The conserved Ipl1/Aurora B protein kinase is a regulator of the SAC that localizes to kinetochores, spindles, spindle midzone, and the midbody ([@B25]; [@B11]). Ipl1 ensures that inappropriate kinetochore--microtubule interactions are destabilized, leading to unattached kinetochores and activation of the SAC ([@B31]). Defects in biorientation are observed in *Saccharomyces cerevisiae ipl1* mutants ([@B3]; [@B37]). Ipl1 substrates such as Dam1 and Ndc80, together with additional targets of Ipl1, are critical for establishing chromosome biorientation ([@B1]; [@B22]; [@B38]).

Despite the differences in centromeres, several components of the kinetochore and posttranslational modifications (PTMs) of centromeric histone H4 are conserved across species ([@B23]; [@B13]; [@B18]). The conserved centromeric histone H3 variant CenH3 (Cse4 in *S. cerevisiae*, CENP-A in *Homo sapiens*) is essential for chromosome segregation ([@B16]). CenH3 homologues have a conserved histone H3--like C-terminal region and a unique N-terminus, and both are essential for kinetochore function ([@B4]). In humans, the N-terminus of CENP-A is phosphorylated by Aurora kinase, and this contributes to kinetochore function and cytokinesis ([@B42], [@B43]; [@B26]). CenH3 phosphorylation has also been reported in maize ([@B44]). In *S. cerevisiae* Cse4 is ubiquitinated and methylated, and in vitro studies indicate that the C-terminal histone fold domain can be phosphorylated ([@B8]; [@B20]; [@B32]; [@B33]). Given the important role of core histone PTMs in epigenetic regulation, CenH3 PTMs may be critical for chromosome segregation ([@B14]). We use mass spectrometry to identify PTMs of Cse4 and focus on phosphorylation. On the basis of in vivo and in vitro results, we conclude that *S. cerevisiae* Cse4 is a substrate of Ipl1 and phosphorylation of Cse4 serves to destabilize defective kinetochores to promote biorientation and ensure faithful chromosome segregation.

RESULTS
=======

PTMs of Cse4 identified by mass spectrometry occur at evolutionarily conserved locations
----------------------------------------------------------------------------------------

Cse4 purified from a wild-type strain expressing either *His-HA-CSE4* or *His-HA-cse4-15KR* ([@B36]) was analyzed by liquid chromatography--tandem mass spectrometry (LC-MS/MS). Several phosphorylation sites (Ser-22, Ser-33, Ser-40, and Ser-105), one methylation site (Arg-37), and one acetylation (Lys-49) site were identified in the N-terminus of Cse4 ([Figure 1A](#F1){ref-type="fig"} and [Table 1](#T1){ref-type="table"}). Methylation of Arg-37 was recently reported ([@B33]). Five of the PTMs (Ser-22, Ser-33, Arg-37, Ser-40, and Lys-49) are contained within region that is evolutionarily conserved among different fungi with point centromeres and includes the essential N-terminal domain ([@B12]; [Figure 1B](#F1){ref-type="fig"}). For this study, we focus on phosphorylation.

![Amino acids in Cse4 that are posttranslationally modified are evolutionarily conserved. (A) Cse4 is phosphorylated, methylated, and acetylated. The peptides identified by mass spectrometry are underlined, and the modified amino acid residues indicated (also see [Table 1](#T1){ref-type="table"}). The essential N-terminal domain (END) is shaded (amino acids 28--60). (B) The region containing the PTM sites within the Cse4 N-terminus is conserved. ClustalW alignment of the Cse4 END regions of point centromere yeasts. Alignment in logo format is shown at the bottom ([@B34]).](2034fig1){#F1}

###### 

Modified peptides identified in vivo by LC-MS/MS.

  Protein     Peptide sequence          Modification
  ----------- ------------------------- ----------------------
  Cse4-15KR   ^20^SLS\#NVNR^26^         S22 phosphorylation
              ^27^LAGDQQS\#INDR^37^     S33 phosphorylation
              ^27^LAGDQQSINDR\#^\#37^   R37 methylation
              ^103^THS\#YALDR^110^      S105 phosphorylation
  Cse4        ^27^ALS\#LLQR^27^         S40 phosphorylation
              ^47^ATK\#NLFPR^54^        K49 acetylation

Centromeric association of phosphorylated Cse4 is increased in cells treated with nocodazole or depleted of cohesion
--------------------------------------------------------------------------------------------------------------------

To facilitate detection of Cse4 phosphorylation, we generated a phosphoserine-specific antibody (αp-Cse4) and tested the specificity of the antibody using hemagglutinin (HA)-tagged *CSE4* or *cse4-4SA* and *cse4-4SD* alleles in which Ser-22, Ser-33, Ser-40, and Ser-105 were substituted with the nonmodifiable or phosphomimetic amino acid alanine or aspartate, respectively (Supplemental Figure 1A). The antibody showed a strong reduction in reactivity to *cse4-4SA* compared with *CSE4* and *cse4-4SD* ([Figure 2A](#F2){ref-type="fig"}). This result demonstrates that αp-Cse4 exhibits differential affinities depending on the phosphorylation state of the four phosphorylated serines in Cse4. The reduced reactivity in protein samples treated with calf intestine phosphatase (CIP) validates the specificity of the αp-Cse4 for phosphorylated Cse4 ([Figure 2B](#F2){ref-type="fig"}). The strong signal with *cse4-4SD* suggests that the aspartate side chain allows recognition by αp-Cse4 ([Figure 2A](#F2){ref-type="fig"}), analogous to results from studies with a *mps1* phosphomimetic mutant ([@B39]).

![Centromeric association of phosphorylated Cse4. (A) Specificity of Cse4 phospho antibody (αp-Cse4). Western blots of Cse4 proteins purified from strains (BY4741) expressing wild-type Cse4 (pMB1601), cse4-4SA (pMB1566), or cse4-4SD (pMB1563) were probed with αHA (loading control) or αp-Cse4. (B) Phosphatase treatment of Cse4 reduces affinity of αp-Cse4 to Cse4. Cse4 protein purified from BY4741 expressing wild-type Cse4 (pMB1601) was treated with or without CIP and analyzed by Western blots probed with αHA (loading control) or αp-Cse4. (C) Phosphorylated Cse4 is associated with centromeres. ChIP of extracts treated with (CIP) or without CIP (no CIP) was performed with αHA or αp-Cse4 (YMB8378) and assayed by PCR for CEN3 and CEN4 sequences. The graph shows an example of a single experiment. Analysis of four independent experiments and statistical significance are shown in D. (D) Ratios of αHA/input DNA and αp-Cse4/αHA signals normalized to the no-CIP condition. Four independent biological replicates were performed. Error bars show the mean ± 95% confidence intervals. Statistical significance was determined by paired *t* test. Open symbols, CEN3; filled symbols, CEN4. (E) Centromere-associated phosphorylated Cse4 is increased in nocodazole-treated cells. ChIP samples from wild-type strain (YMB8378) treated with α-factor or nocodazole were analyzed as described in C. The αp-Cse4 signals (normalized to αHA) before and after CIP treatment were calculated. Results from two independent experiments were pooled. Lines on the scatter plots show the mean ± SE of the mean. Statistical significance was determined by one-way analysis of variance (ANOVA). Open symbols, CEN3; filled symbols, CEN4. (F) Phosphorylation of Cse4 is increased in cells depleted of Scc1. ChIP was performed on strain YMB8674 arrested in metaphase (Cdc20 OFF) with defective cohesion (Scc1 OFF). The control strain (Scc1 ON) was grown in galactose medium. Fraction of phospho-Cse4 is the fraction of the total αp-Cse4 signal removed by CIP treatment. Results from two independent experiments were pooled and plotted as in D. Significance was determined by *t* test. Open symbols, CEN3; filled symbols, CEN4.](2034fig2){#F2}

To examine the association of phosphorylated Cse4 with centromeres, we used our αp-Cse4 in chromatin immunoprecipitation (ChIP) experiments ([Figure 2C](#F2){ref-type="fig"}). Cross-linked chromatin samples treated or not treated with CIP from a strain expressing HA-tagged CSE4 from its own promoter at the endogenous chromosomal locus were analyzed using centromere-specific primers (CEN3, CEN4). Serial dilutions of the input DNA were used to determine that the PCR amplification conditions were in the linear range (Supplemental Figure 2A). No enrichment of Cse4 (αHA) or phosphorylated Cse4 (αp-Cse4) at a noncentromeric control region (actin gene) was observed (data not shown). We quantified the centromeric association of Cse4 (αHA) relative to input DNA and that of phosphorylated Cse4 (αp-Cse4) relative to total Cse4 at centromeres (αHA) in CIP-treated and untreated samples ([Figure 2C](#F2){ref-type="fig"}). Analysis of four independent experiments and statistical significance is shown in [Figure 2D](#F2){ref-type="fig"}. As expected, no significant difference (*p* \> 0.74) in the level of centromeric association of Cse4 (αHA) in response to CIP treatment was observed; however, recognition of phosphorylated Cse4 by αp-Cse4 was significantly reduced after CIP treatment compared with the untreated sample (*p* \< 0.008), indicating that phosphorylated Cse4 associates with centromeric DNA.

Given the essential role of Cse4 in kinetochore function and the centromeric association of phosphorylated Cse4, we asked whether phosphorylation is enhanced upon treatment with a microtubule-depolymerizing agent such as nocodazole or reduced tension between the sister chromatids by depletion of cohesion. ChIP experiments using cells treated with α-factor or nocodazole ([Figure 2E](#F2){ref-type="fig"}) showed higher levels (*p* \< 0.05) of phosphorylated Cse4 at centromeres of cells in the G2/M phase of the cell cycle (nocodazole) compared with G1 (α-factor; [Figure 2E](#F2){ref-type="fig"}). The level of phosphorylated Cse4 at centromeres was further enhanced (*p* \< 0.05) in cells depleted for the cohesion subunit Scc1, a condition that leads to reduced tension between the sister kinetochores ([@B21]; [Figure 2F](#F2){ref-type="fig"}). Levels of total Cse4 (α-HA) at centromeres remained unchanged regardless of the phosphorylation status, indicating that the affinity of Cse4 for centromeres is not affected by phosphorylation. Taken together, our results show that Cse4 phosphorylation is increased at centromeres with defective kinetochore--microtubule attachment or reduced tension.

*cse4* phosphomimetic mutants suppress *ipl1-2*, and Ipl1 contributes to phosphorylation of Cse4 in vivo and in vitro
---------------------------------------------------------------------------------------------------------------------

Destabilization of inappropriate kinetochore--microtubule interactions mediated by Ipl1 phosphorylation of substrates in the kinetochore constitutes an essential step to resolve biorientation defects ([@B31]). Given the increased phosphorylation of Cse4 at centromeres with defective kinetochore--microtubule attachment or reduced tension and the known role of Ipl1 in ensuring biorientation, we tested a potential role of Ipl1 for Cse4 phosphorylation in vivo.

We performed ChIP experiments using *ipl1-2* ([@B9]) and its isogenic wild-type control strain. We observed that the phosphorylated Cse4 signal at CEN3 and CEN4 was markedly reduced (*p* = 0.0038) in the *ipl1-2* strain compared with the wild-type strain ([Figure 3A](#F3){ref-type="fig"}). The difference is pronounced at 33°C, the nonpermissive temperature for *ipl1-2* strains. The reduced centromeric association of phosphorylated Cse4 in the *ipl1-2* strain at 33°C is not due to altered expression of Cse4 in these strains (Supplemental Figure 3A).

![Ipl1 phosphorylates Cse4 in vivo and in vitro and phosphomimetic *cse4-4SD* suppresses temperature sensitivity of an *ipl1-2* strain. (A) Ipl1 contributes to the phosphorylation of centromere-associated Cse4. ChIP experiments were performed with WT (YMB8525) and *ipl1-2* (YMB8528) strains grown at 25°C and shifted to 33°C for 3 h. The p-Cse4 signal is plotted, with lines showing the mean ± SE of the mean. Results from two independent experiments were pooled. Statistical significance was analyzed by two-way ANOVA (strain, temperature), which indicated that observed variation was significant and predominately due to differences between the wild-type and *ipl1-2* strains (*p* = 0.0038). Results of pairwise tests were corrected for multiple comparisons (Bonferroni). Open symbols, CEN3; filled symbols, CEN4. (B) Phosphomimetic *cse4-4SD* suppresses the temperature sensitivity of an *ipl1-2* strain. Serial dilutions of *ipl1-2* (KT1963) with *CSE4* (YMB8528), *cse4-4SA* (YMB8529), or *cse4-4SD* (YMB8530) were plated on YPD medium and incubated at the indicated temperatures for 2--3 d. (C) Ipl1 phosphorylates Cse4 in vitro. Products of in vitro kinase assays using purified Cse4, ATP, and Ipl1-Sli15 at 30°C for 90 min were analyzed by mass spectrometry. Cse4 modification sites are shown, along with those identified by in vivo analysis ([Figure 1A](#F1){ref-type="fig"}; also see [Tables 1](#T1){ref-type="table"} and [2](#T2){ref-type="table"} and Supplemental Figure 3B).](2034fig3){#F3}

The *ipl1-2* strains exhibit a temperature-sensitive phenotype for growth. If lethality of *ipl1-2* at the nonpermissive temperature is partly due to lower levels of phosphorylated Cse4, we reasoned that a phosphomimetic of Cse4, *cse4-4SD*, should suppress the temperature sensitivity of an *ipl1-2* strain. Indeed, results from viability assays showed that the *cse4-4SD* phosphomimetic mutant, but not *cse4-4SA*, partially suppressed the growth defect of *ipl1-2* at 30°C ([Figure 3B](#F3){ref-type="fig"}).

To examine whether Ipl1 phosphorylates Cse4 directly, we performed in vitro kinase assays using Ipl1, Sli15, and Cse4 purified from *Escherichia coli* followed by LC-MS/MS analysis. Phosphorylation at Ser-22, Ser-40, and Ser-105 was detected, as previously by in vivo analysis ([Figure 1A](#F1){ref-type="fig"}). In addition, the in vitro assays showed phosphorylation of Tyr-106, Ser-124, and Ser-148 ([Figure 3C](#F3){ref-type="fig"} and [Table 2](#T2){ref-type="table"}). No phosphorylation was detected from control in vitro assays containing purified Cse4 but lacking Ipl1-Sli15 (data not shown). Furthermore, we performed an in vitro assay containing radiolabeled ATP. With increasing incubation time (5--90 min) we observed increased phosphorylation of Cse4 and Ipl1 (Supplemental Figure 3B). Ipl1 autophosphorylates, and this serves as internal positive control. No phosphorylation was observed after 90 min in the control sample without the kinase Ipl1-Sli15. These results support our conclusion that Ipl1 contributes to phosphorylation of Cse4 in vivo and in vitro.

###### 

Modified peptides identified in vitro by LC-MS/MS.

  Protein                      Peptide sequence       Modification
  ---------------------------- ---------------------- ----------------------
  Cse4 in vitro (Ipl1/Sli15)   ^20^SLS\#NVNR^26^      S22 phosphorylation
                               ^38^ALS\#LLQR^44^      S40 phosphorylation
                               ^103^THS\#YALDR^110^   S105 phosphorylation
                               ^103^THSY\#ALDR^110^   Y106 phosphorylation
                               ^122^KQS\#LKR^127^     S124 phosphorylation
                               ^148^S\#TDLLISK^155^   S148 phosphorylation

*cse4* phosphomimetic mutants suppress growth and chromosome segregation defects of Ipl1 substrate mutant *dam1 spc34*
----------------------------------------------------------------------------------------------------------------------

Given the results for phosphorylation of Cse4 by Ipl1, we tested whether *cse4* phosphomimetic mutants could suppress mutants of Ipl1 substrates Dam1, Spc34, and Ndc80, which mediate remodeling of kinetochore--microtubule interactions ([@B10]; [@B1]; [@B21]). A partially nonphosphorylatable *dam1-3SA* (S257A S265A S292A) strain exhibits a chromosome segregation defect when combined with *spc34-TA* (T199A), which encodes another subunit of the Dam1 complex ([@B10]). We observed that *cse4-4SD* suppressed the temperature sensitivity of *dam1-3SA spc34-TA* strain, whereas this strain showed slightly increased temperature sensitivity when combined with *cse4-4SA* ([Figure 4A](#F4){ref-type="fig"}). To further understand the molecular basis for the *cse4-4SD*--mediated suppression of growth we measured the segregation of a single GFP-labeled chromosome. Our results show that *cse4-4SD* suppresses chromosome missegregation of the *dam1-3SA spc34-TA* strains at 37°C by almost 50% compared with *CSE4* (*p* \< 0.001) and *cse4-4SA* (*p* \< 0.01), nearly to levels observed at 25°C (*p* \< 0.01; [Figure 4, B and C](#F4){ref-type="fig"}). *CSE4, cse4-4SA*, and *cse4-4SD* did not show chromosome segregation defects in a wild-type strain background (Supplemental Figure 3C).

![Phosphomimetic *cse4-4SD* suppresses phenotypes of nonphosphorylatable *dam1 spc34* and *ndc80* strains. (A) Suppression of temperature sensitivity of *dam1 spc34* strains by *cse4-4SD.* Serial dilutions of *dam1-3SA scp34-TA* (DDY2503) with *CSE4* (YMB8390), *cse4-4SA* (YMB8458), or *cse4-4SD* (YMB8393) were assayed for growth at the indicated temperatures on YPD medium for 2--3 d. (B, C) Suppression of chromosome segregation of *dam1 spc34* by *cse4-4SD.* Segregation of a GFP-labeled chromosome (GFP) in strains from A grown at 25 or 37°C was assayed as described in *Materials and Methods*. Fluorescence images in B show examples of normal or missegregation events scored and quantified in (C). DAPI staining shows the position of the nucleus in each of the cells. Statistical significance was determined by two-way ANOVA (strain, temperature), correcting for multiple comparisons (Bonferroni). \*\*\**p* \< 0.001, \*\**p* \< 0.01; ns, not significant. Error bars represent SE of the mean. In each of three independent experiments at least 100 cells were counted for each strain. (D) Suppression of benomyl sensitivity of *ndc80-7SA* by *cse4-4SD.* Serial dilutions of *ndc80-7A* (SBY7123) with *CSE4* (YMB8395), *cse4-4SA* (YMB8087), or *cse4-4SD* (YMB8086) were assayed for growth on YPD containing 15 μg/ml benomyl (or DMSO as control) at 30°C for 4 d.](2034fig4){#F4}

Analogous to the results for the *dam1-3SA spc34-TA*, expression of *cse4-4SD* in an *ndc80-7A* strain suppressed its benomyl sensitivity; *CSE4* or *cse4-4SA* had no effect ([Figure 4D](#F4){ref-type="fig"}). The suppression phenotypes by *cse4-4SD* are not due to altered expression of the *cse4* proteins, as Western blots showed that *dam1-3SA spc34-TA* and *ndc80-7SA* strains express equivalent levels of Cse4, cse4-4SA, or cse4-4SD when grown at permissive and nonpermissive temperatures (Supplemental Figure 3A). Taken together, our results show that *cse4* phosphomimetic mutants suppress phenotypes of Ipl1 substrate mutants *dam1 spc34* and *ndc80.* The suppression of growth and chromosome segregation defects of *dam1 spc34* by *cse4-4SD* suggests that phosphorylation of Cse4 may serve to destabilize kinetochores with defective microtubule attachments and promote biorientation when other Ipl1 substrates cannot be fully phosphorylated.

*cse4* phosphorylation mutants lead to growth defects and increased chromosome segregation defects in kinetochore mutants *okp1* and *ame1*
-------------------------------------------------------------------------------------------------------------------------------------------

If phosphorylation of Cse4 destabilizes defective kinetochore attachments, we reasoned that *cse4* phosphomimetic mutants combined with kinetochore mutants should result in defects in chromosome segregation and growth. For these studies we used mutants in the kinetochore COMA complex, which interacts with Cse4 ([@B30]; [@B5]). The *okp1-5* and *ame1-4* mutants with *cse4-4SD* displayed enhanced temperature sensitivity, which was more severe for the *ame1-4* strains, with little or no growth even at 30°C ([Figure 5A](#F5){ref-type="fig"}). Wild-type strains with *CSE4* or *cse4-4SA* or *cse4-4SD* did not exhibit growth defects at the different temperatures we tested ([Figure 5A](#F5){ref-type="fig"}). The growth defect of *okp1-5 cse4-4SD* and *ame1-4 cse4-4SD* strains is not due to altered Cse4 expression, as Western blot analysis showed that levels of Cse4, cse4-4SA, and cse4-4SD are similar in *okp1-5* and *ame1-4* strains grown at 25 or 33°C (Supplemental Figure 3A).

![*cse4* phosphorylation mutations cause growth defects and increased chromosome segregation defects in *okp1* and *ame1* strains. (A) Enhanced temperature sensitivity of *cse4* phosphorylation mutants in *okp1* and *ame1* strains. Serial dilutions of wild-type strain (DDY1925), *okp1-5* (YV167), or *ame1-4* (YV171) with *CSE4* (YMB8378, YMB8384, YMB8654), *cse4-4SA* (YMB8382, YMB8388, YMB8655), or *cse4-4SD* (YMB8379, YMB8386, YMB8656) were assayed at the indicated temperatures on YPD medium for 2--3 d. (B, C) *cse4-4SD* enhances the chromosome segregation defects of *okp1-5* (B) and *ame1-4* (C) strains. Strains expressing either *CSE4* (YMB8384, YMB8672) or *cse4-4SD* (YMB8386, YMB8673) were arrested with α-factor and shifted to 33 and 30°C, respectively, for 3 h. Segregation of a GFP-labeled chromosome was scored in large-budded cells undergoing mitosis (*n* \> 35), and missegregation of the GFP-labeled chromosome was quantified as described in [Figure 4B](#F4){ref-type="fig"} and *Materials and Methods.* Error bars represent mean deviations for two independent experiments.](2034fig5){#F5}

We next examined the strains for chromosome segregation defects and observed that chromosome missegregation was increased twofold in the *okp1-5 cse4-4SD* strain compared with *okp1-5 CSE4* ([Figure 5B](#F5){ref-type="fig"}). Consistent with previous reports ([@B24]), the *ame1-4* mutants showed higher chromosome missegregation compared with the *okp1-5* strain, which was further increased by 2.5-fold with *cse4-4SD* ([Figure 5C](#F5){ref-type="fig"}). On the basis of our results, we propose that destabilization of the kinetochore by constitutive phosphorylation of Cse4 is detrimental in conjunction with mutations in COMA components.

DISCUSSION
==========

In this study we identified phosphorylation, acetylation, and methylation sites in Cse4 and showed that these sites are located within a region conserved in other point centromere yeasts. We generated a phosphoserine antibody and observed that the association of phosphorylated Cse4 with centromeres is increased in cells treated with nocodazole or with reduced cohesion between sister chromatids. Our results provide evidence that Ipl1 contributes to phosphorylation of Cse4 for faithful chromosome segregation. For example, we showed 1) phosphorylation of Cse4 using in vitro kinase assays with Ip1/Sli15 and agreement of these data with the in vivo mass spectrometry analysis, 2) significantly reduced levels of phosphorylated Cse4 at centromeres in an *ipl1-2* strain at the nonpermissive temperature, 3) suppression of temperature sensitivity of *ipl1-2* and Ipl1 substrate mutants *dam1 spc34* and *ndc80-7SA* by a *cse4* phosphomimetic mutant *cse4-4SD*, and 4) suppression of chromosome segregation defects of *dam1 spc34* by *cse4-4SD.* Our results also show that *cse4* phosphorylation mutants lead to growth defects and increased chromosome segregation defects in kinetochore mutants *okp1* and *ame1.* On the basis of our results, we propose that phosphorylation of Cse4 destabilizes defective kinetochores to promote biorientation and faithful chromosome segregation.

Phosphorylation of CENP-A was reported almost a decade ago, and one of these studies showed that this modification plays a role in cytokinesis ([@B42], [@B43]; [@B26]). To the best of our knowledge, there have been no other reports on the function of phosphorylated CENP-A. In *S. cerevisiae* Cse4 was shown to be methylated and ubiquitinated, and in vitro studies indicate that the C-terminal histone fold domain can be phosphorylated ([@B8]; [@B20]; [@B32]; [@B33]). The observed sequence similarity of the region containing most of the identified PTM sites among the different related yeasts suggests that this region has an important function and that the modifications may also be conserved ([Figure 1B](#F1){ref-type="fig"}).

The phosphoserine antibody (αp-Cse4) that we generated provided a tool for characterization of Cse4 phosphorylation. This antibody showed a clear preference for binding to the phosphomimetic form of Cse4 (4SD) compared with the nonphosphorylatable form (4SA; [Figure 2A](#F2){ref-type="fig"}). The recognition of *cse4-4SD* suggests that the aspartate chain allows the recognition by αp-Cse4. Analogous observations were made in studies using a phosphospecific antibody for Mps1 ([@B39]). The ability of the antibody to distinguish specifically between phosphorylated and nonphosphorylated Cse4 allowed us to determine whether phosphorylated Cse4 is associated with centromeres. Using αp-Cse4, we showed that Cse4 phosphorylation is increased at centromeres with defective kinetochore--microtubule attachment or reduced cohesion between sister chromatids. Similar findings were reported for enhanced recognition of phosphoepitopes at kinetochores by a 3F3/2 antibody in response to tension defects induced by Taxol treatment ([@B19]). 3F3/2 recognizes phosphoepitopes on kinetochores and spindle pole bodies in many cell types. Our study provides a first report of the association of a phosphorylated inner kinetochore protein to centromeric DNA in budding yeast.

Genetic and biochemical analysis showed that Ipl1 contributes to the phosphorylation of Cse4. The partial suppression of the temperature sensitivity of *ipl1-2* by *cse4-4SD* ([Figure 3B](#F3){ref-type="fig"}) is similar to the previously reported suppression of *ipl1-2* by phosphomimetic *dam1* at the semipermissive temperature ([@B10]). That *cse4-4SD* only partially suppresses the *ipl1-2* growth defect suggests that *cse4-4SD* cannot compensate for the lack of phosphorylation of all other Ipl1 substrates, such as Ndc80, Dam1, Cep3, Ipl1, Spc34, Ask1, Sli15, Mif2, and Dsn1, in the *ipl1* mutant ([@B10]; [@B41]).

Our results for in vitro kinase assays using Ipl1, Sli15, and Cse4 showed phosphorylation at Ser-22, Ser-40, and Ser-105 consistent with our in vivo analysis ([Figure 1A](#F1){ref-type="fig"}). The failure to detect phosphorylation of Ser-33 in the in vitro assay may be due to the sensitivity of the assay or the possibility that this site is a substrate for another kinase such as Mps1, Cdc5, Cdc28, or Bub1. The differences in phosphorylation sites of Cse4 identified in vitro and in vivo may also be due to the nature of the substrate (purified Cse4 vs. chromatin), the increased amount of in vitro sample, or the conditions of the in vitro assay. In addition, Ser-148 is within the Cse4 histone fold domain, which mediates histone--histone interactions in the nucleosome core, and it is possible that this site is masked in vivo. [@B22]) also observed additional phosphorylation sites for Dam1 in vitro compared with those observed in vivo by mass spectrometry.

Ipl1-mediated phosphorylation of Dam1 and Ndc80 leads to destabilization of inappropriate kinetochore--microtubule interactions, thereby allowing cells to reestablish proper attachments ([@B31]). We propose that phosphorylation of Cse4 affects the structure and conformation of the kinetochore to destabilize aberrant kinetochore and microtubule attachments for faithful chromosome segregation. A prediction of this model is the destabilization of defective kinetochore attachments and error correction by phosphomimetic *cse4-4SD* when Dam1 or Ndc80 cannot be phosphorylated by Ipl1. Consistent with our hypothesis, we see suppression of the temperature sensitivity of *dam1 spc34* strains and benomyl sensitivity of *ndc80-7SA* strains by *cse4-4SD*. Given that chromosome segregation defects contribute to the temperature sensitivity of *dam1 spc34* strains, we investigated the molecular basis for the suppression by *cse4-4SD* by using a cell biology approach with a GFP- labeled reporter chromosome. As expected, our results showed that *cse4-4SD* suppressed chromosome missegregation of the *dam1 spc34* strains at 37°C by almost 50% compared with *CSE4* and *cse4-4SA*, nearly to levels observed at 25°C. These results are quite striking, given that the assay uses only one labeled reporter chromosome, and suggest that the robust suppression of the growth phenotype by *cse4-4SD* may be due to error correction of more than one defective kinetochore.

Cse4 interacts with the COMA complex, which has two essential (Okp1 and Ame1) and two nonessential subunits (Mcm21 and Ctf19; [@B17]). Okp1 has a role in establishing tension across sister kinetochores ([@B17]), and *okp1-5* strain exhibits synthetic lethality with *cse4* mutants ([@B12]). Furthermore, [@B33]) recently reported synthetic growth defects of a methylation mutant of *CSE4*, namely *cse4-R37A*, in *ame1-4* and *okp1-5* strains. We observed increased temperature sensitivity and chromosome missegregation defects in *cse4-4SD ame1-4* and *cse4-4SD okp1-5* strains. These results suggest that constitutive phosphorylation of Cse4 may destabilize even bioriented kinetochores if the kinetochore is already weakened due to defects in the COMA complex.

In conclusion, we identified PTMs in Cse4 in a region that is evolutionarily conserved and showed that Ipl1-mediated phosphorylation of Cse4 regulates chromosome segregation. We showed that the association of phosphorylated Cse4 with centromeres is increased in cells treated with nocodazole or with reduced cohesion between sister chromatids. Our results provide evidence that Ipl1 contributes to phosphorylation of Cse4 in vivo and in vitro. On the basis of genetic interactions of *cse4* with kinetochore mutants, we propose that phosphorylation of Cse4 destabilizes defective kinetochores to promote biorientation and chromosome segregation. Future studies will help us understand the role of Cse4 phosphorylation by Ipl1 or other potential kinases in destabilizing defective kinetochores to promote biorientation and maintain genome stability.

MATERIALS AND METHODS
=====================

Yeast strains and plasmids
--------------------------

Plasmids and yeast strains used in this study are described in [Tables 3](#T3){ref-type="table"} and [4](#T4){ref-type="table"}, respectively. *S. cerevisiae* strains are isogenic to BY4741, W303-1A, or YPH499 (S288C). For genetic interaction analysis, a PCR-based method was used to replace endogenous *CSE4* with HA-tagged *CSE4 or cse4* phosphorylation mutant alleles expressed from their own promoters in wild-type, *okp1-5*, *dam1 spc34*, and *ndc80-7SA* strains. Primers used to amplify natMX sequence were, for first PCR, mx4F3 and mxR4, and for second PCR, mx4F3 and cse4dn. Primers used to amplify CSE4 sequence were cse4up and mxR2 (for primers see [Table 5](#T5){ref-type="table"}). Gene replacement of *CSE4* with the integrated alleles was verified by sequence analysis, and Western blots confirmed the expression of the HA-tagged protein. At least two independent strains were analyzed for each experiment. For interactions of *cse4* phosphorylation mutants with *ame1-4* and *ipl1-2*, the *cse4* alleles were introduced into heterozygous *ame1-4* or *ipl1-2* diploids, and independently derived double mutants were obtained by tetrad dissection.

###### 

Plasmids used in this study.

  Name      Promoter, gene, and marker                                   Source
  --------- ------------------------------------------------------------ ------------
  pYES2     *GAL1, 2 μ, URA3*                                            
  pMB1313   *GAL-8His-HA-cse4-K15R+C (2 μm/URA3)*                        This study
  pMB1345   *GAL-8His-HA-CSE4 (2 μm/URA3)*                               This study
  pMB1601   *GAL-6His-3HA-CSE4 (2 μm/URA3)*                              This study
  pMB1566   *GAL-6His-3HA-cse4-4SA (S22A S33A S40A S105A) (2 μm/URA3)*   This study
  pMB1563   *GAL-6His-3HA-cse4-4SD (S22D S33D S40D S105D) (2 μm/URA3)*   This study
  pRB199    *6His-3HA-CSE4 (YCp/URA3)*                                   This study
  pMB1462   *6His-3HA-cse4-4SA (S22A S33A S40A S105A)(YCp/URA3)*         This study
  pMB1463   *6His-3HA-cse4-4SD (S22D S33D S40D S105D) (YCp/URA3)*        This study

###### 

Yeast strains used in this study.

  Strain (parent)            Relevant genotype                                                                                                                          Source
  -------------------------- ------------------------------------------------------------------------------------------------------------------------------------------ ----------------------------------
  BY4741                     *MAT*a *his3Δ1 leu2Δ0 met15Δ0 ura3Δ0*                                                                                                      Open Biosystems (Huntsville, AL)
  DDY1925                    *Mat*a *his3-∆200 ura3-52 ade2-1 HIS::pCu-lac1-GFP leu2-3112::lacO::LEU2*                                                                  Cheeseman *et al*. (2002)
  DDY2503                    *MAT*a*, his3∆200, ura3-52, HIS3::pCu-LacI-GFP, leu2-3112::lacO::LEU2, dam1(S257A S265A S292A)::KanMX, spc34∆::HIS3, spc34(T199A)::URA3*   [@B10])
  KT1113                     *MATα leu2 ura3-52 his3*                                                                                                                   [@B35])
  KT1963                     *MAT*a *leu2 ura3-52 his3 ipl1-2*                                                                                                          [@B2])
  YMB8303 (S288C)            *Matα ura3-52his3Δ200 leu2 lys2-201 ade2-201 trp1Δ63*                                                                                      [@B6])
  SBY7123 (W303)             *MAT*a *ura3-1::ndc80-7A::URA3 ndc80*Δ*HIS3 PDS1-myc18:LEU2*                                                                               [@B1])
  T6984                      *Mat*a *∆scc1::TRP leu::GAL-SCC1::LEU ade::TetR-GFP::ADE his::tetOS::HIS MET-CDC20::TRP, Ura-auxotroph*                                    [@B21])
  W303-1A                    *MAT*a *ade2 ura3 trp1 leu2 his3 can1 ssd1*                                                                                                [@B45]
  YV167                      *Mat*a *okp1-5:TRP1 his3-11,15::LacI:GFP:HIS3 CEN15:LacO:URA3 SPC29:CFP:KanMX*                                                             [@B24])
  YV171                      *Mat*a *ame1-4:TRP1 his3-11,15::LacI:GFP:HIS3 CEN15:LacO:URA3 SPC29:CFP:KanMX*                                                             [@B24])
  YMB7239 (YMB7273)          *MAT*a *cse4∆::KanMX pYES2-8His-HA-CSE4 (pMB1345)*                                                                                         This study
  YMB7273 (BY4741)           *MAT*a*/α cse4∆::KanMX*                                                                                                                    Open Biosystems
  YMB8086 (SBY7123)          *MAT*a *CSE4:: 6His-3HA-cse4-4SD (S22D S33D S40D S105D)::mx4NAT*                                                                           This study
  YMB8087 (SBY7123)          *MAT*a *CSE4:: 6His-3HA-cse4-4SA (S22A S33A S40A S105A)::mx4NAT*                                                                           This study
  YMB8378 (DDY1925)          *MAT*a *CSE4:: 6His-3HA-CSE4::mx4NAT*                                                                                                      This study
  YMB8379 (DDY1925)          *MAT*a *CSE4:: 6His-3HA-cse4-4SD (S22D S33D S40D S105D)::mx4NAT*                                                                           This study
  YMB8382 (DDY1925)          *MAT*a *CSE4:: 6His-3HA-cse4-4SA (S22A S33A S40A S105A)::mx4NAT*                                                                           This study
  YMB8384 (YV167)            *MAT*a *CSE4:: 6His-3HA-CSE4::mx4NAT*                                                                                                      This study
  YMB8386 (YV167)            *MAT*a *CSE4:: 6His-3HA-cse4-4SD (S22D S33D S40D S105D)::mx4NAT*                                                                           This study
  YMB8388 (YV167)            *MAT*a *CSE4:: 6His-3HA-cse4-4SA (S22A S33A S40A S105A)::mx4NAT*                                                                           This study
  YMB8390 (DDY2503)          *MAT*a *CSE4:: 6His-3HA-CSE4::mx4NAT*                                                                                                      This study
  YMB8393 (DDY2503)          *MAT*a *CSE4:: 6His-3HA-cse4-4SD (S22D S33D S40D S105D)::mx4NAT*                                                                           This study
  YMB8395 (SBY7123)          *MAT*a *CSE4:: 6His-3HA-CSE4::mx4NAT*                                                                                                      This study
  YMB8458 (DDY2503)          *MAT*a *CSE4:: 6His-3HA-cse4-4SA (S22A S33A S40A S105A)::mx4NAT*                                                                           This study
  YMB8525 (KT1113)           *MATα CSE4::6His-3HA-CSE4::mx4NAT*                                                                                                         This study
  YMB8528 (KT1963)           *MAT*a *CSE4:: 6His-3HA-CSE4::mx4NAT*                                                                                                      This study
  YMB8529 (KT1963)           *MAT*a *CSE4:: 6His-3HA-cse4-4SA (S22A S33A S40A S105A)::mx4NAT*                                                                           This study
  YMB8530 (KT1963)           *MAT*a *CSE4:: 6His-3HA-cse4-4SD (S22D S33D S40D S105D)::mx4NAT*                                                                           This study
  YMB8651 (YMB8303, YV171)   *MAT*a*/α AME1/ame1-4:TRP1 CSE4/CSE4Δ::6His-3HA-CSE4::mx4NAT*                                                                              This study
  YMB8652 (YMB8303, YV171)   *MAT*a*/α AME1/ame1-4:TRP1 CSE4/CSE4Δ::6His-3HA-cse4 4SA (S22A S33A S40A S105A)::mx4NAT*                                                   This study
  YMB8653 (YMB8303, YV171)   *MAT*a*/α AME1/ame1-4:TRP1 CSE4/CSE4Δ::6His-3HA-cse4 4SD (S22D S33D S40D S105D)::mx4NAT*                                                   This study
  YMB8654 (YMB8651)          *MAT*a *ame1-4:TRP1 CSE4Δ::6His-3HA-CSE4::mx4NAT his3-11,15::LacI:GFP:HIS3 SPC29:CFP:KanMX*                                                This study
  YMB8655 (YMB8652)          *MAT*a *ame1-4:TRP1 CSE4Δ::6His-3HA-cse4 4SA (S22A S33A S40A S105A)::mx4NAT his3-11,15::LacI:GFP:HIS3 SPC29:CFP:KanMX*                     This study
  YMB8656 (YMB8653)          *MAT*a *ame1-4:TRP1 CSE4Δ::6His-3HA-cse4 4SD (S22D S33D S40D S105D)::mx4NAT his3-11,15::LacI:GFP:HIS3 SPC29:CFP:KanMX*                     This study
  YMB8672 (YMB8651)          *MAT*a *ame1-4:TRP1 CSE4Δ::6His-3HA-CSE4::mx4NAT his3-11,15::LacI:GFP:HIS3 CEN15:LacO:URA3*                                                This study
  YMB8673 (YMB8653)          *MAT*a *ame1-4:TRP1 CSE4Δ::6His-3HA-cse4 4SD (S22D S33D S40D S105D)::mx4NAT his3-11,15::LacI:GFP:HIS3 CEN15:LacO:URA3*                     This study
  YMB8674 (T6984)            *pRB199*                                                                                                                                   This study

###### 

Primers used in this study.

  Name     Short description                                    Sequence (5′--3′)
  -------- ---------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------
  mx4F3    Forward to amplify natMX sequence                    AGA TCT GTT TAG CTT GCC TCG TCC
  mxR4     Reverse to amplify natMX sequence                    GAA AAA TCG GCT CCA GCC CTG AAG ACA AAA TAT CAG AAT TCG AGC TCG TTT TCG ACA CTG
  cse4dn   Used in second PCR with mx4F3 to add CSE4 sequence   TAA TAT GAC CTT ATA ATA ACC TTA TTT AAA ACA TTT AAA GTA CCT TAA GTC AAT ATA AAC CCC GAA AAA GGG AAA AAT CGG CTC CAG CCC
  cse4up   Forward to amplify CSE4 sequence                     AAA AAC AGT AGT AGA TAA TCT TGA GAA TTT ACT TTA TAA AAA ACA GAA GAA GGA CTG AAT
  mxR2     Reverse to amplify CSE4 sequence                     GAC CCG GCG GGG ACG AGG CAA GCT AAA CAG ATC TGA AAT ATA GGG GAC TGC C
  OMB244   Forward CEN3                                         GAT CAG CGC CAA ACA ATA TGG
  OMB245   Reverse CEN3                                         AAC TTC CAC CAG TAA ACG TTT C
  OMB764   Forward CEN4                                         GCG CAA GCT TGC AAA AGG TCA CAT G
  OMB765   Reverse CEN4                                         CGA ATT CAT TTT GGC CGC TCC TAG GTA

Mass spectrometry
-----------------

Cse4 was purified from a wild-type strain (BY4741) overexpressing either *His-HA-CSE4* (pMB1345) or *His-HA-cse4-15KR* (pMB1313) under conditions designed to maximize detection of PTM sites ([@B36]). Samples for mass spectrometry were separated on a 4--12% denaturing Bis-Tris SDS-polyacrylamide gel (Invitrogen, Carlsbad, CA) and stained with Coomassie brilliant blue. Bands corresponding to Cse4 and Cse415KR were excised, reduced, alkylated, and digested with trypsin in situ. Mass spectrometry was done as described previously with minor modifications ([@B40]). The volume injected was 7 μl, and electrospray potential was 1.78 kV. We used the *S. cerevisiae* proteome database (containing 5861 protein sequences; [www.expasy.org](http://www.expasy.org), downloaded July 2007) for analysis of the data.

Growth and chromosome segregation assays
----------------------------------------

For growth assays, a fivefold serial dilution of cells was spotted on 1% yeast extract, 2% bactopeptone, and 2% glucose (YPD), YPD with dimethyl sulfoxide (DMSO), or 15 μg/ml benomyl in DMSO. For chromosome segregation assays, *dam1 spc34* strains were grown in YPD medium supplemented with a final concentration of 0.8 mM adenine to reduce background fluorescence and 250 μM CuSO~4~ to induce expression of the LacI-GFP fusion reporter. Cultures were grown at the permissive temperature (25°C) and then shifted to either the permissive or the nonpermissive temperature (37°C) and grown overnight. Cells were fixed for 5 min in 4% methanol-free formaldehyde and resuspended in phosphate-buffered saline (PBS) containing 10 μg/ml 4′,6-diamidino-2-phenylindole (DAPI). Only cells with resolved GFP foci or large-budded cells each with a separate nucleus (identified by DAPI fluorescence) were used for quantification purposes. To be scored as normal chromosome segregation, the GFP-labeled chromosomes colocalized within the nucleus of unbudded cells or in each of separated nuclei in large-budded cells. For scoring missegregation, we counted cells that contained more than one GFP focus within a single nucleus or large-budded cells in which one nuclear mass was devoid of GFP foci. A Zeiss Axioskop 2 (Carl Zeiss, Jena, Germany) with 100× objective numerical aperture (NA) ∼1.4 was used to image cells. Chromosome segregation assays with *okp1* and *ame1* strains were essentially as described previously ([@B24]). In brief, cells were grown at 25°C overnight in SC-HIS with fivefold excess adenine. The next day, cells were diluted into SC-HIS with fivefold excess adenine and 40 mM 3-amino adipate for ∼2 h in the presence of α-factor (RP01002; GenScript, Piscataway, NJ) to arrest cells in G1. Cells were shifted to the semipermissive temperature (33°C for *okp1* and 30°C for *ame1*) for 1 h. Cells were released into pheromone-free medium, and samples were collected ∼2 h after release, when most cells were in mitosis, fixed for 5 min in 4% methanol-free formaldehyde, and resuspended in PBS containing DAPI (10 μg/ml). Chromosome segregation was assayed in mitotic cells. For normal chromosome segregation the GFP-labeled centromeres colocalized with the nucleus in each of the large-budded cells with separated nuclei. For chromosome missegregation we quantified cells that contained more than one GFP focus within a single nucleus or cells in which one cell contains a nucleus devoid of GFP foci. A DeltaVision microscope work station (Applied Precision, Issaquah, WA) was used with 100× objective NA ∼1.4 to acquire *Z*-stacks. The *Z*-stack for each field of cells was imaged such that the entire depth of the cells was included to ensure collection of the total fluorescence from every cell. ImageJ software (National Institutes of Health, Bethesda, MD) was used to construct projections from each set of *Z*-stacks.

Cell cycle arrest and depletion of cohesion experiments
-------------------------------------------------------

Cells were grown in YPD to logarithmic phase and treated with 3 μM α-factor (RP01002; GenScript) for 135 min (G1) or 20 μg/ml nocodazole (M1404; Sigma-Aldrich, St. Louis, MO) for 150 min (G2/M). To confirm cell cycle arrest, cellular morphology was monitored and DNA content determined by flow cytometric analysis, as described previously ([@B29]; Supplemental Figure 2B). Samples were analyzed using a Becton-Dickinson FACSCalibur flow cytometer and Cell Quest software (BD Biosciences, Franklin Lakes, NJ). For experiments evaluating the centromeric association of phosphorylated Cse4 in response to reduced tension, we used a well-characterized reporter strain in which expression of Scc1 is controlled by the *GAL1* promoter and that of Cdc20 by the *MET3* promoter ([@B21]). ChIP experiments were carried out using cells that were arrested by α-factor (G1) in methionine-free media (Cdc20 ON) containing galactose (Scc1 ON) and then shifted to medium containing glucose (Scc1 OFF) and methionine (Cdc20 OFF). Cell biology approaches have shown lack of sister chromatid cohesion and reduced tension in this strain under the experimental conditions used ([@B21]). Controls included strains grown continuously in galactose medium containing methionine, a condition that allows expression of Scc1, while repressing Cdc20.

Protein analysis and generation of phosphospecific Cse4 antibody
----------------------------------------------------------------

We generated phosphospecific Cse4 antibodies (αp-Cse4) using peptides corresponding to the Cse4-Ser-33 site with N-terminal cysteine residues (H2N-CLAGDQQ(Sp)IND-amide). Polyclonal antibodies were raised against the conjugated phosphopeptide in rabbits by New England Peptide (Gardner, MA) and affinity purified. Secondary antibodies were horseradish peroxidase--conjugated (HRP) sheep anti-mouse immunoglobulin G (IgG; NA931V; Amersham, Piscataway, NJ) and HRP-conjugated sheep anti-rabbit IgG (NA934V; Amersham). To purify histidine-tagged Cse4 protein from *S. cerevisiae*, (8--16) × 10^8^ cells were disrupted using glass beads and vortexing (75 min) in 500 μl of lysis buffer (0.1 M Tris, pH 8.0, 6 M guanidine chloride, 0.5 M NaCl). Extracts were clarified by centrifugation and incubated with nickel-charged Superflow NTA resin (Qiagen, Valencia, CA) for 1 h at room temperature and washed once with lysis buffer and three times with washing buffer (100 mM Tris-Cl, pH 8.0, 20% glycerol, 1 mM phenylmethylsulfonyl fluoride). The bound protein was eluted by boiling in 2× Laemmli sample buffer with 200 mM imidazole. Samples were resolved by SDS--PAGE on 4--12% Bis-Tris SDS-polyacrylamide gels (NP0322BOX; Novex, San Diego, CA). Blots were washed with TBST (Tris-buffered saline plus 0.1% Tween 20) three times for 10 min. Western blot analysis was done using primary antibodies α-HA (16B12; BAbCO, Richmond, CA) or αp-Cse4 (0.5 μg/ml) in TBST containing 5% (wt/vol) dried skim milk. ImageJ software was used for quantification of Western blot signals. Western blot analysis showed reactivity of the αp-Cse4 antibody to *cse4-Ser-33^A^* (data not shown).

ChIP experiments
----------------

For ChIP experiments, cultures grown to logarithmic phase or arrested with α-factor or treated with nocodazole or upon deletion of cohesion were treated with formaldehyde (final 1%) for 20 min at 30°C, followed by addition of 2.5 M glycine for 5 min at 30°C. Cells were washed twice with 1× PBS, resuspended in 0.7 ml of breaking buffer (0.1 M Tris, pH 8.0, 20% glycerol, protease inhibitor cocktail \[P8215; Sigma-Aldrich\]), and lysed by vortexing for 1 h at 4°C in presence of glass beads. Cell lysate was added to 1 ml FA buffer (50 mM Na--4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid \[HEPES\], pH 7.6, 1 mM EDTA, 1% Triton X-100, 150 mM NaCl, 0.1% Na deoxycholate) with protease inhibitor cocktail. After centrifugation the chromatin pellet was resuspended in FA buffer and sonicated on ice at 10% output power 10 times for 15 s. The resulting soluble chromatin fraction was denoted as input and treated or not treated with 200 U/ml alkaline CIP (MA M0290L; New England BioLabs, Ipswich, MA) for 1 h at 37°C. Immunoprecipitation was carried out using Dynabeads Protein A (100.02D, Invitrogen) coated with antibodies (αHA \[16B12; BAbCO\], αp-Cse4 \[Basrai lab\], no antibody) overnight at 4°C. The immunoprecipitated DNA--protein complexes were washed for 5 min at room temperature, each wash in FA buffer (twice), FA-HS buffer (50 mM Na-HEPES, pH 7.6, 1 mM EDTA, 1% Triton X-100, 500 mM NaCl, 0.1% Na deoxycholate; twice), RIPA buffer (10 mM Tris pH 8.0, 1 mM EDTA, 250 mM LiCl, 0.5% Nonidet P40, 0.5% Na deoxycholate; twice), and TE (pH 8.0; once), and finally resuspended in elution buffer (25 mM Tris, pH 7.6, 10 mM EDTA, 0.5% SDS). For the input control, the input sample was diluted in 2× Stop buffer (20 mM Tris, pH 8.0, 100 mM NaCl, 20 mM EDTA, 1% SDS). All samples were incubated overnight at 65°C to reverse the cross-linking. After centrifugation, supernatant was treated with 0.7 mg/ml Proteinase K (AM2546; Ambion, Austin, TX) at 55°C for 4--5 h. After phenol/chloroform/isoamyl alcohol extraction, the immunoprecipitated DNA was ethanol precipitated at −80°C overnight. Twenty-microliter PCRs were performed using primer pairs for at least two different centromeric sequences (0.5 μM primers \[ [Table 5](#T5){ref-type="table"}\], 1× HotStar-Taq polymerase Master Mix \[203445; Qiagen\], denaturation at 94°C for 1 min, annealing at 55°C for 1 min, and extension at 68°C for 45 s for 25--27 cycles). Ten-microliter PCR products were resolved on a 1.6% agarose gel containing ethidium bromide. Quantification of bands on agarose gels used GeneSnap software (Syngene, Frederick, MD). Linear range of quantification was verified by analyzing serial dilutions of input DNA (Supplemental Figure 2A).

In vitro assays for phosphorylation of Cse4
-------------------------------------------

Cse4 was produced in *E. coli* and purified by Sephacryl-S200 chromatography as described ([@B28]) and was phosphorylated with purified GST-Ipl1 and GST-Sli15 (kindly donated by Trisha Davis, University of Washington, Seattle, WA). The 100-μl reaction contained 10 μg of Cse4, 0.5 μM GST-Ipl1, 0.5 μM GST-Sli15 (residues 554--698), 200 mM NaCl, 10 mM ATP, 25 mM MgCl~2~, and 50 mM HEPES buffer, pH 7.2. Reactions were incubated at 30°C for 90 min. Control reactions lacked GST-Ipl1 and GST-Sli15. The samples were run on 4--12% Bis-Tris SDS-polyacrylamide gels (Invitrogen) and the Cse4 bands excised and analyzed by mass spectrometry as described. For in vitro assays using radiolabeled ATP a 20-μl reaction contained 1 μg of Cse4, 0.5 μM GST-Ipl1, 0.5 μM GST-Sli15, 25 mM Tris-HCl pH 7.5, 2 mM dithiothreitol, 10 mM MgCl~2~, 0.5 mM EDTA, 100 μM ATP, and 1 μCi of \[γ-^32^P\]ATP. Reactions were incubated at 30°C for 5, 15, 30, and 90 min. Reactions were stopped with 5 μl of 4× NuPAGE LDS loading buffer (Life Technologies, Grand Island, NY) and boiled for 5 min at 95°C. Control reactions lacked GST-Ipl1 and GST-Sli15. The samples were run on 4--12% Bis-Tris SDS-polyacrylamide gels (Invitrogen) and stained with Coomassie blue, and radiolabeled proteins were detected using a Storm Detector (GE Healthcare, Piscataway, NJ).
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ANOVA

:   analysis of variance

CEN3

:   centromere of chromosome 3

CenH3

:   centromeric histone H3 variant

ChIP

:   chromatin immunoprecipitation

CIP

:   calf intestine phosphatase

COMA

:   complex of Ctf19, Okp1, Mcm21, and Ame1

END

:   essential N-terminal domain

HA

:   hemagglutinin

PTM

:   posttranslation modification
